West Pharmaceutical Services Beat Expectations

West Pharmaceutical Services (WST) reported earnings of $1.84 per share on revenue of $766.50 million for the second quarter ended June 2025. The consensus earnings estimate was $1.51 per share on revenue of $726.00 million. The Earnings Whisper number was $1.57 per share. The company beat expectations by 17.20% while revenue grew 9.17% on a year-over-year basis.

The company said it expects 2025 earnings of $6.65 to $6.85 per share on revenue of $3.04 billion to $3.06 billion. The company's previous guidance was earnings of $6.15 to $6.35 per share on revenue of $2.945 billion to $2.975 billion and the current consensus earnings estimate is $6.29 per share on revenue of $2.97 billion for the year ending December 31, 2025.

West Pharmaceutical Services Inc is a manufacturer of components & systems for injectable drug delivery, plastic packaging, delivery system components. Its products include stoppers and seals for vials, prefillable syringe components and systems.